Titre : Acides gras trans

Acides gras trans : Questions médicales fréquentes

Termes MeSH sélectionnés :

Biomedical Technology
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acides gras trans : Questions médicales les plus fréquentes", "headline": "Acides gras trans : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acides gras trans : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-27", "dateModified": "2025-02-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acides gras trans" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acides gras insaturés", "url": "https://questionsmedicales.fr/mesh/D005231", "about": { "@type": "MedicalCondition", "name": "Acides gras insaturés", "code": { "@type": "MedicalCode", "code": "D005231", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.251.355" } } }, "about": { "@type": "MedicalCondition", "name": "Acides gras trans", "alternateName": "Trans Fatty Acids", "code": { "@type": "MedicalCode", "code": "D044242", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Qiang Wang", "url": "https://questionsmedicales.fr/author/Qiang%20Wang", "affiliation": { "@type": "Organization", "name": "Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences/Key Laboratory of Agro-Products Processing, Ministry of Agriculture, Beijing 100194, PR China. Electronic address: wangqiang06@caas.cn." } }, { "@type": "Person", "name": "Parvaneh Mirabi", "url": "https://questionsmedicales.fr/author/Parvaneh%20Mirabi", "affiliation": { "@type": "Organization", "name": "Infertility and Reproductive Health Research Center. Health Research Institute. Babol University of Medical Sciences, Babol, Iran." } }, { "@type": "Person", "name": "Inge Huybrechts", "url": "https://questionsmedicales.fr/author/Inge%20Huybrechts", "affiliation": { "@type": "Organization", "name": "International Agency for Research on Cancer, 69372 Lyon, France." } }, { "@type": "Person", "name": "Farkas Sarnyai", "url": "https://questionsmedicales.fr/author/Farkas%20Sarnyai", "affiliation": { "@type": "Organization", "name": "Semmelweis University, Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Budapest, Hungary." } }, { "@type": "Person", "name": "Judit Mátyási", "url": "https://questionsmedicales.fr/author/Judit%20M%C3%A1ty%C3%A1si", "affiliation": { "@type": "Organization", "name": "B&B Analytics Ltd., Érd, Hungary." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37019064", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vhri.2023.02.002" } }, { "@type": "ScholarlyArticle", "name": "Adaptive Health Technology Assessment: A Scoping Review of Methods.", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37285917", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jval.2023.05.017" } }, { "@type": "ScholarlyArticle", "name": "Living Health Technology Assessment: Issues, Challenges and Opportunities.", "datePublished": "2023-01-18", "url": "https://questionsmedicales.fr/article/36652184", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40273-022-01229-4" } }, { "@type": "ScholarlyArticle", "name": "The economic imperatives for technology enabled wellness centered healthcare.", "datePublished": "2022-08-03", "url": "https://questionsmedicales.fr/article/35922479", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1057/s41271-022-00356-8" } }, { "@type": "ScholarlyArticle", "name": "Bibliometric Analysis of Health Technology Research: 1990~2020.", "datePublished": "2022-07-25", "url": "https://questionsmedicales.fr/article/35897415", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19159044" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Acides gras", "item": "https://questionsmedicales.fr/mesh/D005227" }, { "@type": "ListItem", "position": 4, "name": "Acides gras insaturés", "item": "https://questionsmedicales.fr/mesh/D005231" }, { "@type": "ListItem", "position": 5, "name": "Acides gras trans", "item": "https://questionsmedicales.fr/mesh/D044242" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acides gras trans - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acides gras trans", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acides gras trans", "description": "Comment détecte-t-on les acides gras trans dans les aliments ?\nQuels tests sanguins révèlent la présence d'acides gras trans ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acides gras trans", "description": "Quels symptômes sont liés à une consommation élevée d'acides gras trans ?\nLes acides gras trans causent-ils des maladies cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acides gras trans", "description": "Comment prévenir les effets des acides gras trans ?\nQuels aliments éviter pour réduire les acides gras trans ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acides gras trans", "description": "Comment traiter les effets des acides gras trans ?\nY a-t-il des médicaments pour contrer les effets des acides gras trans ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acides gras trans", "description": "Quelles complications peuvent survenir avec les acides gras trans ?\nLes acides gras trans affectent-ils la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acides gras trans", "description": "Quels sont les facteurs de risque liés aux acides gras trans ?\nLes jeunes sont-ils plus à risque des acides gras trans ?", "url": "https://questionsmedicales.fr/mesh/D044242?mesh_terms=Biomedical+Technology&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les acides gras trans dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Par analyse chimique, souvent via chromatographie, pour mesurer leur concentration." } }, { "@type": "Question", "name": "Quels tests sanguins révèlent la présence d'acides gras trans ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de lipides sanguins mesurent les niveaux de cholestérol et de triglycérides." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une consommation élevée d'acides gras trans ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inclure des douleurs thoraciques, fatigue et problèmes digestifs." } }, { "@type": "Question", "name": "Les acides gras trans causent-ils des maladies cardiaques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur consommation est liée à une augmentation du risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment prévenir les effets des acides gras trans ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments transformés et lire les étiquettes nutritionnelles attentivement." } }, { "@type": "Question", "name": "Quels aliments éviter pour réduire les acides gras trans ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les margarines, les fritures et les produits de boulangerie industriels." } }, { "@type": "Question", "name": "Comment traiter les effets des acides gras trans ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Réduire leur consommation et adopter un régime riche en acides gras insaturés bénéfiques." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour contrer les effets des acides gras trans ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments hypolipémiants peuvent aider à gérer les niveaux de lipides sanguins." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les acides gras trans ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent entraîner des maladies cardiaques, obésité et diabète de type 2." } }, { "@type": "Question", "name": "Les acides gras trans affectent-ils la santé mentale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre leur consommation et des troubles de l'humeur." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque liés aux acides gras trans ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en aliments transformés et un mode de vie sédentaire augmentent le risque." } }, { "@type": "Question", "name": "Les jeunes sont-ils plus à risque des acides gras trans ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes consomment souvent plus d'aliments transformés, augmentant leur exposition." } } ] } ] }

Sources (10000 au total)

Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?

The introduction of digital health technologies (DHTs) that have the potential to improve health outcomes and lower the costs of healthcare services has seen an explosion in recent years. Indeed, the ... We examine the regulatory landscape, health technology assessment process, and reimbursement coverage determination for DHTs in Korea.... We identified the specific challenges and opportunities for reimbursement coverage of DHTs.... To ensure DHTs can be used effectively in medical practice, a more flexible and nontraditional approach to assessment, reimbursement, and payment determination is required....

Adaptive Health Technology Assessment: A Scoping Review of Methods.

Health technology assessment (HTA) is an established mechanism for explicit priority setting to support universal health coverage. However, full HTA requires significant time, data, and capacity for e... The objectives of this scoping review were to identify and map existing aHTA methods, and to assess their triggers, strengths, and weaknesses. This was done by searching HTA agencies' and networks' we... This review identified 20 countries and 1 HTA network with aHTA methods in the Americas, Europe, Africa, and South-East Asia. These methods have been characterized into 5 types: rapid reviews, rapid c... aHTA is used in many settings. It has potential to improve the efficiency of any priority-setting system, but needs to be better formalized to improve uptake, particularly for nascent HTA systems....

Requirements for building educational and care technology on heart failure.

to investigate the requirements for building an educational and care application about heart failure.... exploratory study, carried out with 15 people with heart failure and 19 family members/caregivers, assisted in a tertiary unit in the Brazilian Northeast. Individual semi-structured interviews were ca... two units of meaning emerged: "The plurality of care in heart failure" and "Expectations on the construction and use of educational and care technology for heart failure". The requirements involved th... requirements on educational and care technology were identified and will support the creation of an application that promotes care, aiming to obtain positive health outcomes....

Approaches to Evaluating Digital Health Technologies: Scoping Review.

Profound scientific evaluation of novel digital health technologies (DHTs) is key to enhance successful development and implementation. As such, we previously developed the eHealth evaluation cycle. T... The aim of this study is to develop a better understanding of the daily practice of the eHealth evaluation cycle. Therefore, the objectives are to conduct a structured analysis of literature data to a... We conducted a systematic literature search in PubMed including the MeSH term "telemedicine" in combination with a wide variety of evaluation approaches. Original peer-reviewed studies published in th... We included 824 studies after 1583 titles and abstracts were screened. The majority of the evaluation studies focused on the effectiveness (impact; 304/824, 36.9%) study phase, whereas uptake (impleme... We composed the first comprehensive overview of the actual practice of implementing consecutive DHT evaluation study phases. We found that the study phases of the eHealth evaluation cycle are unequall...

Future health technology trends, policy, and governance perspective: the Turkish case.

Advanced health technologies that emerge with the development of technology have an impact on health systems. This study aimed to determine the effects of these technologies on Türkiye's health system... Interviews were conducted with senior managers, bureaucrats, policy-makers and decision-makers from seven different institutions on the subject. Content analysis was performed on the data obtained and... It was concluded that these technologies would not have a positive impact on two identified themes, a negative impact on seven themes and a predominant impact on five themes in Türkiye.... To adapt to the new health ecosystem in Türkiye, it is recommended to increase digital literacy, conduct economic evaluations of technologies, promote domestic production, ensure up-to-date follow-up,...